Register
Login:
Share:
Email Facebook Twitter


James Bevan on cybersecurity, banks and the housing market


Premaitha Share Price (NIPT)



Share Price Information for Premaitha (NIPT)


Share Price: 10.50Bid: 10.25Ask: 10.75Change: 0.00 (0.00%)No Movement on Premaitha
Spread: 0.50Spread as %: 4.88%Open: 10.50High: 10.50Low: 10.50Yesterday’s Close: 10.50

Premaitha Health Plc Ord 0.1P

Premaitha is listed in the FTSE AIM All-Share
Premaitha is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
10.50

Share Price SpacerBid
10.25

Share Price SpacerAsk
10.75

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
168,413

Share Price SpacerOpen
10.50

Share Price SpacerHigh
10.50

Share Price SpacerLow
10.50

Share Price SpacerClose
10.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 321.22m £33.73m 20,000

52 Week High 13.88 52 Week High Date 6-MAR-2017
52 Week Low 7.38 52 Week Low Date 3-FEB-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
6 168,413 0 -1.750 -6.00 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

24-May-17
14:47:13
10.3205
4,000
Sell* 
10.25
10.75
412.82
Trade Type:
Ordinary

24-May-17
14:06:56
10.3205
5,000
Sell* 
10.25
10.75
516.03
Trade Type:
Ordinary

24-May-17
09:24:28
10.429
100,000
Sell* 
10.25
10.75
10.43k
Trade Type:
Ordinary




View more Premaitha trades >>

Directors Deals for Premaitha (NIPT)
Trade DateActionNotifierPriceCurrencyAmountHolding
17-Dec-15Buy
Trade Notifier Information for Premaitha Health
Barry Kenneth Hextall held the position of CFO at Premaitha Health at the time of this trade.
 Barry Kenneth Hextall
18.03GBX180,736332498
02-Nov-15Notification of Holding
Trade Notifier Information for Premaitha Health
William Denman held the position of Chief Medical Officer at Premaitha Health at the time of this trade.
 William Denman
00250000
02-Jul-15Placing
Trade Notifier Information for Premaitha Health
Barry Kenneth Hextall held the position of CFO at Premaitha Health at the time of this trade.
 Barry Kenneth Hextall
20GBX150,000151762
View more Premaitha directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Tue 21:53notaflipperRE: Esperite10.50No Opinion
2016 Annual Report is published here:
http://www.esperite.com/?p=6119

Scroll right to the end where it talks about a going concern. They refer specifically to the L1 Capital Financing conditions which is currently uncertain to be met but which can be waived unconditionally. Does not look like the shareholders will have to await till July for further news. AGM was just a placeholder to buy some time
Tue 15:05twix386The10.50No Opinion
Agenda etc can be downloaded from www.esperite.com
Tue 15:03twix386Esperite10.50No Opinion
Esperite is convening an AGM for 4th July.

Should be interesting!
Mon 20:41SheephatchTelegraph article10.50No Opinion
New NHS test could lead to abortions of 'undesirable' babies, warn experts
13 Comments
A baby grips the finger of its mother
Women come under pressure to abort girls, the Nuffield Council on Bioethics claims CREDIT: DESIGN PICS INC/REX/SHUTTERSTOCK
Sarah Knapton, science editor
22 MAY 2017 • 1:04AM
A blood test which reveals the sex of a baby after nine weeks as well as identifying undesirable traits should be restricted to avoid parents aborting their babies for spurious… Read More
Mon 12:04bakkyRE: Genoma appeal10.375No Opinion
Looks like their own auditors need some answers from the board before they will sign off accounts, not looking good for Esperite!!

Esperite N.V. (Euronext: ESP, the “Company” or “Esperite“) announces that additional time is needed for the Company to publish its Annual Report for the fiscal year ended 31 December 2016. This further delay is a consequence of the recently announced court ordered bankruptcy of Genoma S.A., a Swiss wholly-owned subsidiary of Esperite… Read More
Mon 10:16bakkyRE: Genoma appeal10.375No Opinion
Esperite getting even further away from their Eur 0.70 figure they need to maintain to secure funding. I can't see it getting anywhere near that figure as things stand so Esperite will go down the pan too it seems, or is it that simple?

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Premaitha (NIPT) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.